Literature DB >> 17546328

Institutional change and political decision-making in the creation of the Brazilian National Health Surveillance Agency.

Márcia Franke Piovesan1, Maria Eliana Labra.   

Abstract

This article examines the decision-making process that led to the creation of the Brazilian National Health Surveillance Agency (ANVISA) in 1999. The authors begin by discussing the history of the Agency's predecessor, the Health Surveillance Secretariat, and the need for its modernization to adjust the quality of the products under its control to domestic and international demands. From the theoretical perspective of neo-institutionalism, the article goes on to analyze the social and political context surrounding the debate on the proposed alternatives to adjust Health Surveillance to new rules in line with such requirements, focusing especially on the formulation of the new policy, the decision-making arena, and the actors with specific interests in the sector. The research drew on extensive documentary and media material, plus interviews with key actors. The article concludes that a determinant factor for the creation of ANVISA was the favorable domestic political context, fostering a positive correlation of forces that (in an extremely short timeframe, 1998-1999) allowed the creation of the first regulatory agency in the social policies area in Brazil.

Mesh:

Year:  2007        PMID: 17546328     DOI: 10.1590/s0102-311x2007000600012

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  2 in total

1.  Regulatory reliance to approve new medicinal products in Latin American and Caribbean countries.

Authors:  Carlos E Durán; Martín Cañás; Martín A Urtasun; Monique Elseviers; Tatiana Andia; Robert Vander Stichele; Thierry Christiaens
Journal:  Rev Panam Salud Publica       Date:  2021-04-09

2.  The politics of COVID-19 vaccination in middle-income countries: Lessons from Brazil.

Authors:  Elize Massard da Fonseca; Kenneth C Shadlen; Francisco I Bastos
Journal:  Soc Sci Med       Date:  2021-06-02       Impact factor: 5.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.